Antinociceptive Interaction of intrathecal alpha(2)-adrenergic agonists, tizanidine and clonidine, with lidocaine in rats

被引:40
作者
Kawamata, T
Omote, K
Kawamata, M
Iwasaki, H
Namiki, A
机构
[1] Department of Anesthesiology, Sapporo Med. Univ. Sch. of Medicine, Chuo-ku, Sapporo, Hokkaido 060, South 1
关键词
analgesia; anesthetic techniques; intrathecal; anesthetics; local; lidocaine; interactions; (drug); synergy; pain; sympathetic nervous system; alpha(2)-adrenergic agonist; clonidine; tizanidine;
D O I
10.1097/00000542-199708000-00035
中图分类号
R614 [麻醉学];
学科分类号
100217 ;
摘要
Background: The intrathecal alpha(2)-adrenergic agonist, clonidine, has been shown to have considerable antinociceptive effect, although clonidine causes hypotension and bradycadia. The combination of intrathecal clonidine and local anesthetics enhances analgesic effects, whereas the combination may cause marked hypotension and motor blockade, which may limit the clinical application of the combination. Tizanidine, another alpha(2)-adrenergic agonist, has also provided antinociception without producing pronounced hemodynamic changes, This study was designed to evaluate the antinociceptive and hemodynamic interactions of tizanidine and clonidine with lidocaine. Methods: Male Sprague Dawley rats were chronically implanted with lumbar intrathecal catheters. The tail-flick test was used to assess the thermal nociceptive threshold. The ability of intrathecal tizanidine, clonidine, Lidocaine, or the combinations of alpha(2)-adrenergic agonist and lidocaine to alter the tail-flick latency was examined. To characterize;he antinociceptive interaction, the isobolographic analysis was applied, Additionally , the motor function, blood pressure and heart rate after intrathecal administration of drugs and combinations were also monitored. Results: intrathecal tizanidine, clonidine, or the combinations increased the tail-flick latency in dose-and time-dependent fashion without affecting motor function. The order potencies (dose producing a 50% of peak effect, in mu g) of tizanidine and clonidine were 1.8 and 0.75, respectively, With isobolographic analysis, tizanidine with Lidocaine and clonidine with lidocaine showed significantly synergistic antinociceptive interaction. Potency ratio analysis and fractional analysis also confirmed the synergistic interaction, At the doses in the combinations showing comparable antinociception, tizanidine with Lidocaine, unlike clonidine with lidocaine, did not affect motor function or blood pressure. Conclusion: The authors' results show that intrathecal tizanidine and clonidine synergistically interact with lidocaine so that the degree of antinociception to somatic noxious stimuli are enhanced, The antinociceptive synergistic interaction between tizanidine and lidocaine may be useful in clinical practice without affecting blood pressure, heart rate, or motor function.
引用
收藏
页码:436 / 448
页数:13
相关论文
共 36 条
[1]  
BERENBAUM MC, 1989, PHARMACOL REV, V41, P93
[2]   EFFECTS OF EPINEPHRINE AND CLONIDINE ON PLASMA-CONCENTRATIONS OF SPINAL BUPIVACAINE [J].
BOICO, O ;
BONNET, F ;
MAZOIT, JX .
ACTA ANAESTHESIOLOGICA SCANDINAVICA, 1992, 36 (07) :684-688
[3]  
BOUSQUET P, 1984, J PHARMACOL EXP THER, V230, P232
[4]   SUBARACHNOID CLONIDINE REDUCES SPINAL-CORD BLOOD-FLOW AND GLUCOSE-UTILIZATION IN CONSCIOUS RATS [J].
CROSBY, G ;
RUSSO, MA ;
SZABO, MD ;
DAVIES, KR .
ANESTHESIOLOGY, 1990, 73 (06) :1179-1185
[5]  
DANZEBRINK RM, 1990, J PHARMACOL EXP THER, V253, P698
[6]   EPIDURAL CLONIDINE ANALGESIA FOLLOWING SURGERY - PHASE-I [J].
EISENACH, JC ;
LYSAK, SZ ;
VISCOMI, CM .
ANESTHESIOLOGY, 1989, 71 (05) :640-646
[7]  
FILOS KS, 1994, ANESTHESIOLOGY, V81, P594
[8]   AN ALPHA-2 RECEPTOR MEDIATES THE SELECTIVE-INHIBITION BY NORADRENALINE OF NOCICEPTIVE RESPONSES OF IDENTIFIED DORSAL HORN NEURONS [J].
FLEETWOODWALKER, SM ;
MITCHELL, R ;
HOPE, PJ ;
MOLONY, V ;
IGGO, A .
BRAIN RESEARCH, 1985, 334 (02) :243-254
[9]   BIOCHEMICAL-EVIDENCE FOR PHARMACOLOGICAL SIMILARITIES BETWEEN ALPHA-ADRENORECEPTORS AND VOLTAGE-DEPENDENT NA+ AND CA++ CHANNELS [J].
FRELIN, C ;
VIGNE, P ;
LAZDUNSKI, M .
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1982, 106 (03) :967-973
[10]  
GESSNER PK, 1970, J PHARMACOL EXP THER, V174, P247